4.5 Review

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options

Journal

Publisher

XIA & HE PUBLISHING INC
DOI: 10.14218/JCTH.2016.00069

Keywords

Hepatic encephalopathy; Cirrhosis; Lactulose; Rifaximin

Funding

  1. Ocera Therapeutics

Ask authors/readers for more resources

Hepatic encephalopathy is a spectrum of reversible neuropsychiatric abnormalities, seen in patients with liver dysfunction and/or portosystemic shunting. One of the most debilitating complications of cirrhosis, encephalopathy affects 30-45% of cirrhotics. In addition to significantly affecting the lives of patients and their caregivers, it is also associated with increased morbidity and mortality as well as significant utilization of health care resources. In this paper, we provide an overview on the pathophysiology, diagnosis, management and newer therapies of hepatic encephalopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available